-
Utica Research Institute Achieves Significant Scientific Breakthrough
A five-year study by the Masonic Medical Research Institute has revealed that removing the enzyme PTP1B from heart cells can help prevent heart failure related to obesity and diabetes. Published in “Science Signaling,” the study highlights that PTP1B affects insulin signaling, leading to insulin resistance. By eliminating this enzyme, the heart can regain insulin sensitivity, mitigating risks associated with type 2 diabetes and improving metabolic function. Dr. Maria Kontaridis emphasized the significance of this discovery in reversing harmful metabolic changes in cardiac cells.
